The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations
by Schaper-Gerhardt, Katrin (Author)
, Gutzmer, Ralf (Author)
, Angela, Yenny (Author)
, Zimmer, Lisa (Author)
, Livingstone, Elisabeth (Author)
, Schadendorf, Dirk (Author)
, Hassel, Jessica C. (Author)
, Weishaupt, Carsten (Author)
, Remes, Bernhard (Author)
, Kubat, Linda (Author)
, Spassova, Ivelina (Author)
, Becker, Jürgen C. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource